Edgewise Therapeutics, Inc. SEC filings EWTX
Edgewise Therapeutics, Inc. has 421 filings in SEC EDGAR's recent list, going back to Sep 26, 2019. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 4 | Insider transaction | Oct 2, 2026 | Oct 1, 2026 |
| 4/A | Primary document | Aug 17, 2026 | Aug 12, 2026 |
| 4/A | Primary document | Aug 17, 2026 | Aug 12, 2026 |
| 4/A | Primary document | Aug 17, 2026 | Aug 12, 2026 |
| 4/A | Primary document | Aug 17, 2026 | Aug 12, 2026 |
| 4/A | Primary document | Aug 17, 2026 | Aug 12, 2026 |
| 4 | Insider transaction | Aug 14, 2026 | Aug 12, 2026 |
| 4 | Insider transaction | Aug 14, 2026 | Aug 12, 2026 |
| 4 | Insider transaction | Aug 14, 2026 | Aug 12, 2026 |
| 4 | Insider transaction | Aug 14, 2026 | Aug 12, 2026 |
| 4 | Insider transaction | Aug 14, 2026 | Aug 12, 2026 |
| 4 | Insider transaction | Aug 14, 2026 | Aug 12, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| 144 | Notice of proposed sale | Aug 13, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 6, 2026 | — |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 4 | Insider transaction | Jul 17, 2026 | Jun 5, 2026 |
| 8-K/A | Amended current report | Jul 16, 2026 | Jul 10, 2026 |
| 8-K |
Current report
Acquisition or sale of assets, Regulation FD disclosure
|
Jul 13, 2026 | Jul 10, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jul 1, 2026 |
| 4 | Insider transaction | Jul 1, 2026 | Jul 1, 2026 |
| 144 | Notice of proposed sale | Jul 1, 2026 | — |
| 4 | Insider transaction | Jun 17, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 17, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 17, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 16, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 16, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 16, 2026 | Jun 5, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 5, 2026 | Jun 4, 2026 |
| 8-K |
Current report
Material agreement
|
Jun 1, 2026 | May 31, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| S-8 | Employee stock plan registration | May 7, 2026 | — |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 144 | Notice of proposed sale | May 5, 2026 | — |
| 4 | Insider transaction | May 5, 2026 | May 4, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Apr 27, 2026 | — |
| ARS | Annual report to shareholders | Apr 23, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 23, 2026 | — |
| DEF 14A | Proxy statement | Apr 23, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Apr 3, 2026 | Apr 1, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Apr 1, 2026 |
| 4 | Insider transaction | Mar 31, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Mar 30, 2026 | Mar 27, 2026 |
| 144 | Notice of proposed sale | Mar 27, 2026 | — |
| 10-K | Annual report | Feb 26, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2026 | Feb 26, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| 4 | Insider transaction | Jan 23, 2026 | Jan 21, 2026 |
| 144 | Notice of proposed sale | Jan 21, 2026 | — |
| 144 | Notice of proposed sale | Jan 20, 2026 | — |
| 144 | Notice of proposed sale | Jan 15, 2026 | — |
| 4 | Insider transaction | Jan 5, 2026 | Jan 2, 2026 |
| 144 | Notice of proposed sale | Dec 29, 2025 | — |
| 4 | Insider transaction | Nov 24, 2025 | Nov 19, 2025 |
| 3 | Initial insider ownership | Nov 24, 2025 | Nov 19, 2025 |
| 8-K |
Current report
Officer or director change
|
Nov 20, 2025 | Nov 19, 2025 |
| 144 | Notice of proposed sale | Nov 17, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| 4 | Insider transaction | Nov 13, 2025 | Nov 12, 2025 |
| 4 | Insider transaction | Nov 13, 2025 | Nov 11, 2025 |
| 4 | Insider transaction | Nov 13, 2025 | Nov 10, 2025 |
| 3 | Initial insider ownership | Nov 13, 2025 | Nov 10, 2025 |
| 144 | Notice of proposed sale | Nov 12, 2025 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Nov 10, 2025 | Nov 10, 2025 |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 4 | Insider transaction | Oct 2, 2025 | Oct 1, 2025 |
| 4 | Insider transaction | Aug 28, 2025 | Aug 26, 2025 |
| 144 | Notice of proposed sale | Aug 26, 2025 | — |
| 4 | Insider transaction | Aug 14, 2025 | Aug 12, 2025 |
| 4 | Insider transaction | Aug 14, 2025 | Aug 12, 2025 |
| 4 | Insider transaction | Aug 14, 2025 | Aug 12, 2025 |
| 4 | Insider transaction | Aug 14, 2025 | Aug 12, 2025 |
| 4 | Insider transaction | Aug 14, 2025 | Aug 12, 2025 |
| 4 | Insider transaction | Aug 14, 2025 | Aug 12, 2025 |
| 4 | Insider transaction | Aug 14, 2025 | Aug 12, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 17, 2025 | — |
| 4 | Insider transaction | Jul 2, 2025 | Jul 1, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 26, 2025 | Jun 26, 2025 |
| 4 | Insider transaction | Jun 18, 2025 | Jun 16, 2025 |
| 4 | Insider transaction | Jun 18, 2025 | Jun 16, 2025 |
| 4 | Insider transaction | Jun 18, 2025 | Jun 16, 2025 |
| 4 | Insider transaction | Jun 18, 2025 | Jun 16, 2025 |
| 4 | Insider transaction | Jun 18, 2025 | Jun 16, 2025 |
| 4 | Insider transaction | Jun 18, 2025 | Jun 16, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| DEFA14A | Additional proxy material | May 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 14, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | May 12, 2025 | — |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| 4 | Insider transaction | May 7, 2025 | May 1, 2025 |
| 4 | Insider transaction | May 7, 2025 | May 1, 2025 |
| 4 | Insider transaction | May 7, 2025 | May 1, 2025 |
| 4 | Insider transaction | May 7, 2025 | May 1, 2025 |
| 4 | Insider transaction | May 7, 2025 | May 1, 2025 |
| 4 | Insider transaction | May 7, 2025 | May 1, 2025 |
| DEFA14A | Additional proxy material | Apr 29, 2025 | — |
| DEF 14A | Proxy statement | Apr 29, 2025 | Jun 13, 2025 |
| 4 | Insider transaction | Apr 4, 2025 | Apr 3, 2025 |
| 4 | Insider transaction | Apr 4, 2025 | Apr 3, 2025 |
| 4 | Insider transaction | Apr 3, 2025 | Apr 1, 2025 |
| 424B5 | Prospectus supplement | Apr 2, 2025 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Apr 2, 2025 | Apr 2, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 2, 2025 | Apr 2, 2025 |
| 4 | Insider transaction | Mar 11, 2025 | Mar 7, 2025 |
| 4 | Insider transaction | Mar 11, 2025 | Mar 7, 2025 |
| S-8 | Employee stock plan registration | Mar 3, 2025 | — |
| 10-K | Annual report | Mar 3, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 3, 2025 | Mar 3, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 21, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 14, 2025 | — |
| 4 | Insider transaction | Feb 7, 2025 | Feb 5, 2025 |
| 4 | Insider transaction | Feb 7, 2025 | Feb 5, 2025 |
| 4 | Insider transaction | Feb 7, 2025 | Feb 5, 2025 |
| 144 | Notice of proposed sale | Feb 5, 2025 | — |
| 144 | Notice of proposed sale | Feb 5, 2025 | — |
| 144 | Notice of proposed sale | Feb 5, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 3, 2025 | — |
| 4 | Insider transaction | Jan 30, 2025 | Jan 28, 2025 |
| 144 | Notice of proposed sale | Jan 28, 2025 | — |
| 4 | Insider transaction | Jan 23, 2025 | Jan 21, 2025 |
| 3 | Initial insider ownership | Jan 23, 2025 | Jan 21, 2025 |
| 8-K |
Current report
Officer or director change
|
Jan 22, 2025 | Jan 8, 2025 |
| 4 | Insider transaction | Dec 31, 2024 | Dec 30, 2024 |
| 144 | Notice of proposed sale | Dec 30, 2024 | — |
| 4 | Insider transaction | Dec 27, 2024 | Dec 24, 2024 |
| 144 | Notice of proposed sale | Dec 26, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 16, 2024 | Dec 16, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Nov 12, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 12, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 8, 2024 | — |
| S-8 | Employee stock plan registration | Nov 7, 2024 | — |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| SC 13G | Ownership over 5% (passive) | Oct 22, 2024 | — |
| 4 | Insider transaction | Oct 16, 2024 | Oct 11, 2024 |
| 4 | Insider transaction | Sep 24, 2024 | Sep 20, 2024 |
| 4 | Insider transaction | Sep 24, 2024 | Sep 20, 2024 |
| 4 | Insider transaction | Sep 24, 2024 | Sep 20, 2024 |
| 4 | Insider transaction | Sep 24, 2024 | Sep 20, 2024 |
| 4 | Insider transaction | Sep 24, 2024 | Sep 20, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Sep 23, 2024 | — |
| 144 | Notice of proposed sale | Sep 23, 2024 | — |
| 144 | Notice of proposed sale | Sep 20, 2024 | — |
| 144 | Notice of proposed sale | Sep 20, 2024 | — |
| 144 | Notice of proposed sale | Sep 20, 2024 | — |
| 144 | Notice of proposed sale | Sep 20, 2024 | — |
| 144 | Notice of proposed sale | Sep 20, 2024 | — |
| 4 | Insider transaction | Aug 14, 2024 | Aug 12, 2024 |
| 4 | Insider transaction | Aug 14, 2024 | Aug 12, 2024 |
| 4 | Insider transaction | Aug 14, 2024 | Aug 12, 2024 |
| 4 | Insider transaction | Aug 14, 2024 | Aug 12, 2024 |
| 4 | Insider transaction | Aug 14, 2024 | Aug 12, 2024 |
| 4 | Insider transaction | Aug 14, 2024 | Aug 12, 2024 |
| 4 | Insider transaction | Aug 14, 2024 | Aug 12, 2024 |
| 8-K |
Current report
Officer or director change
|
Aug 12, 2024 | Aug 10, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Jul 10, 2024 | — |
| 4 | Insider transaction | Jun 12, 2024 | Jun 10, 2024 |
| 4 | Insider transaction | Jun 12, 2024 | Jun 10, 2024 |
| 4 | Insider transaction | Jun 12, 2024 | Jun 10, 2024 |
| 4 | Insider transaction | Jun 12, 2024 | Jun 10, 2024 |
| 4 | Insider transaction | Jun 12, 2024 | Jun 10, 2024 |
| 4 | Insider transaction | Jun 12, 2024 | Jun 10, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 11, 2024 | Jun 7, 2024 |
| 8-K |
Current report
Material agreement, Agreement ended
|
May 10, 2024 | May 10, 2024 |
| S-3ASR | Automatic shelf registration | May 10, 2024 | — |
| S-8 | Employee stock plan registration | May 9, 2024 | — |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| 4 | Insider transaction | May 7, 2024 | May 6, 2024 |
| 3 | Initial insider ownership | May 7, 2024 | May 6, 2024 |
| DEFA14A | Additional proxy material | May 7, 2024 | — |
| 8-K |
Current report
Officer or director change
|
May 7, 2024 | May 6, 2024 |
| 4 | Insider transaction | May 3, 2024 | May 1, 2024 |
| 4 | Insider transaction | May 3, 2024 | May 1, 2024 |
| 4 | Insider transaction | May 3, 2024 | May 1, 2024 |
| 4 | Insider transaction | May 3, 2024 | May 1, 2024 |
| 4 | Insider transaction | May 3, 2024 | May 1, 2024 |
| 4 | Insider transaction | May 3, 2024 | May 1, 2024 |
| DEFA14A | Additional proxy material | Apr 26, 2024 | — |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 7, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- EWTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boulder, CO
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1710072
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.